BBOT vs QCOM · $610.4M cap vs P/E 16, rev $44.28B
BridgeBio Oncology Therapeutics, Inc. (BBOT) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company listed on NASDAQ.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
BBOT does not have a complete income-statement cache yet.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
BBOT currently screens at market cap $610.4M. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the BBOT and QCOM stock pages for the full models.
Not investment advice.